News ArticleBliss GVS Pharma Penalized Rs. 1.8 Lakh Each by BSE and NSE for Board Composition Non-Compliance
Company paid fines after delay attributed to internal coordination; no financial impact beyond fines
Bliss GVS Pharma Limited was fined Rs. 1,80,000 by both BSE and NSE for non-compliance with SEBI Listing Regulation 17(1) concerning the composition of its board, including failure to appoint a woman director. The company has paid both fines and is enhancing its compliance monitoring systems.
Bliss GVS Pharma Limited
Legal / Regulatory
Bliss GVS Pharma Limited has been fined Rs. 1,80,000 each by the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) due to non-compliance with Regulation 17(1) of SEBI Listing Regulations related to board composition, including failure to appoint a woman director. The company has paid the fines in full.
The fines imposed represent 0.000269% of the company’s market capitalization at the time of the penalties.
The non-compliance involved not meeting the regulatory requirements for the composition of the board, specifically regarding the appointment of a woman director.
The company acknowledged a delay in disclosing these fines, attributing it to the time needed for internal coordination and verification of the penalties received from the stock exchanges.
Bliss GVS Pharma has expressed regret over the delay and stated it is strengthening its internal reporting and monitoring mechanisms to ensure timely identification and disclosure of material events in compliance with SEBI regulations.
Highlights
- BSE and NSE each imposed a fine of Rs. 1,80,000 excluding GST on Bliss GVS Pharma.
- The fine was due to failure to meet board composition requirements under Regulation 17(1), including appointing a woman director.
- Fines amount to 0.000269% of the company's market capitalization.
- No other financial or operational impacts apart from the fines.
- Delay in filing disclosure caused by internal coordination processes, now being addressed.
- Company has paid the fines in full.
Key Data Snapshot
What happened
- BSE and NSE each imposed fines of Rs. 1,80,000 on Bliss GVS Pharma for non-compliance with Regulation 17(1) of SEBI Listing Regulations.
- The violation involved not fulfilling board composition requirements, including failure to appoint a woman director.
Key details
- Notices of fines received on August 25, 2026.
- Fines represent 0.000269% of company’s market capitalization.
- Company has paid the full fines to both BSE and NSE.
Regulatory and governance context
- The fine relates to Regulation 17(1) of SEBI Listing Regulations, governing composition of the board of directors.
- Bliss GVS Pharma failed to appoint a woman director as required by the regulation.
Risks and conditions
- The company acknowledged a delay in filing the disclosure under Regulation 30, caused by internal coordination and verification delays.
- Bliss GVS Pharma has taken steps to improve internal reporting and monitoring to prevent future delays.
Highlights
- BSE and NSE each imposed a fine of Rs. 1,80,000 excluding GST on Bliss GVS Pharma.
- The fine was due to failure to meet board composition requirements under Regulation 17(1), including appointing a woman director.
- Fines amount to 0.000269% of the company's market capitalization.
- No other financial or operational impacts apart from the fines.
- Delay in filing disclosure caused by internal coordination processes, now being addressed.
- Company has paid the fines in full.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 17(1)
- SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
More News on Legal / Regulatory
View allLatest corporate announcements and market updates in Legal / Regulatory.
Bharat Heavy Electricals Gets Rs. 207.26 Crore GST Demand Dropped for FY 2022-23 by Telangana Tax Authority
Bharat Heavy Electricals Limited (BHEL) announced that the Telangana Commercial Tax Department has dropped the entire Goods and Services Tax (GST) demand of Rs. 207.26 Crore raised for fiscal year 2022-23 following an adjudication order received on November 9, 2026.
Read Full Story
Tata Teleservices Receives Rs. 25,000 Penalty for Violation of Telecom License Conditions
Tata Teleservices (Maharashtra) Limited has been fined Rs. 25,000 by the Department of Telecommunications for alleged violations of subscriber verification and bulk user premises inspection requirements under its Unified License Agreement.
Read Full Story
CG Power Secures Stay from Aurangabad High Court on MPCB Closure of Waluj Manufacturing Unit
CG Power and Industrial Solutions Limited reported that the Aurangabad High Court has stayed the Maharashtra Pollution Control Board's directive to close its Waluj manufacturing unit, preserving an operation that generates roughly 2.5% of the company's annual consolidated revenue.
Read Full Story
